These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2451882)

  • 21. Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Weiss GR; Crowley J; Von Hoff DD; Taylor SA; Belt RJ; Coltman CA; Hynes HE; Costanzi JJ
    Cancer Treat Rep; 1986 Sep; 70(9):1123-4. PubMed ID: 2427196
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II trial of fludarabine phosphate for adenocarcinoma of the pancreas. An Illinois Cancer Center study.
    Kilton LJ; Benson AB; Greenberg A; Johnson P; Shapiro C; Blough R; French S; Weidner L
    Invest New Drugs; 1992 Aug; 10(3):201-4. PubMed ID: 1385353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fludarabine therapy in macroglobulinemic lymphoma.
    Kantarjian HM; Alexanian R; Koller CA; Kurzrock R; Keating MJ
    Blood; 1990 May; 75(10):1928-31. PubMed ID: 1692487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group study.
    Kish JA; Kopecky K; Samson MK; Von Hoff DD; Fletcher WS; Kempf RA; Muggia FM
    Invest New Drugs; 1991 Feb; 9(1):105-8. PubMed ID: 1709151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity.
    Warrell RP; Berman E
    J Clin Oncol; 1986 Jan; 4(1):74-9. PubMed ID: 2416889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract]   [Full Text] [Related]  

  • 27. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
    Keating MJ; Kantarjian H; Talpaz M; Redman J; Koller C; Barlogie B; Velasquez W; Plunkett W; Freireich EJ; McCredie KB
    Blood; 1989 Jul; 74(1):19-25. PubMed ID: 2473795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of fludarabine phosphate for gastric adenocarcinoma. An Illinois Cancer Center trial.
    Kilton LJ; Ashenhurst JB; Wade JL; Schilsky RL; Shiomoto G; Blough RR; French SL; Benson AB
    Invest New Drugs; 1994; 12(2):163-6. PubMed ID: 7532162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors. A Southwest Oncology Group trial.
    Taylor SA; Crowley J; Vogel FS; Townsend JJ; Eyre HJ; Jaeckle KA; Hynes HE; Guy JT
    Invest New Drugs; 1991 May; 9(2):195-7. PubMed ID: 1714887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
    Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Solal-Céligny P; Brice P; Brousse N; Caspard H; Bastion Y; Haïoun C; Bosly A; Tilly H; Bordessoule D; Sebban C; Harousseau JL; Morel P; Dupas B; Plassart F; Vasile N; Fort N; Leporrier M
    J Clin Oncol; 1996 Feb; 14(2):514-9. PubMed ID: 8636765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses of patients to arabinosyladenine-5'-phosphate correlated with an in vitro test.
    Lepage GA; Khaliq A
    Adv Enzyme Regul; 1978; 17():437-54. PubMed ID: 93404
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase I clinical trial of fludarabine phosphate (F-ara-AMP).
    Casper ES; Mittelman A; Kelson D; Young CW
    Cancer Chemother Pharmacol; 1985; 15(3):233-5. PubMed ID: 2414021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.
    Puccio CA; Mittelman A; Lichtman SM; Silver RT; Budman DR; Ahmed T; Feldman EJ; Coleman M; Arnold PM; Arlin ZA
    J Clin Oncol; 1991 Sep; 9(9):1562-9. PubMed ID: 1714949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fludarabine phosphate for the treatment of low grade lymphoid malignancy.
    Whelan JS; Davis CL; Rule S; Ranson M; Smith OP; Mehta AB; Catovsky D; Rohatiner AZ; Lister TA
    Br J Cancer; 1991 Jul; 64(1):120-3. PubMed ID: 1713049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysis pneumonopathy associated with the use of fludarabine phosphate.
    Crowley JJ; Knight L; Charan N
    West J Med; 1994 Dec; 161(6):597-9. PubMed ID: 7531920
    [No Abstract]   [Full Text] [Related]  

  • 37. Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study.
    Spriggs DR; Stopa E; Mayer RJ; Schoene W; Kufe DW
    Cancer Res; 1986 Nov; 46(11):5953-8. PubMed ID: 2428488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
    Boogaerts MA; Van Hoof A; Catovsky D; Kovacs M; Montillo M; Zinzani PL; Binet JL; Feremans W; Marcus R; Bosch F; Verhoef G; Klein M
    J Clin Oncol; 2001 Nov; 19(22):4252-8. PubMed ID: 11709569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary toxicity associated with fludarabine monophosphate.
    Hurst PG; Habib MP; Garewal H; Bluestein M; Paquin M; Greenberg BR
    Invest New Drugs; 1987; 5(2):207-10. PubMed ID: 2443463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I clinical investigation of fludarabine phosphate by a loading-dose and continuous-infusion schedule.
    Leiby JM; Grever MR; Staubus AE; Neidhart JA; Malspeis L
    J Natl Cancer Inst; 1988 May; 80(6):447-9. PubMed ID: 2452888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.